NASDAQ:XRAY - Dentsply Sirona Stock Price, Price Target & More

Get Started

$47.25 +0.05 (+0.11 %)

(As of 05/23/2018 07:54 AM ET)

Previous Close$47.20

Today's Range$47.16 - $47.59

52-Week Range$44.21 - $68.98

Volume1.43 million shs

Average Volume2.81 million shs

Market Capitalization$10.74 billion

P/E Ratio17.76

Dividend Yield0.74%

Beta1.26

About Dentsply Sirona (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Dental equipment & supplies

Sub-IndustryHealth Care Supplies

SectorMedical

SymbolNASDAQ:XRAY

CUSIP24903010

Webwww.dentsplysirona.com

Phone717-845-7511

Debt

Debt-to-Equity Ratio0.25

Current Ratio2.23

Quick Ratio1.46

Price-To-Earnings

Trailing P/E Ratio17.76

Forward P/E Ratio18.31

P/E Growth2.38

Sales & Book Value

Annual Sales$3.99 billion

Price / Sales2.69

Cash Flow$11.25 per share

Price / Cash4.20

Book Value$29.48 per share

Price / Book1.60

Profitability

EPS (Most Recent Fiscal Year)$2.66

Net Income$-1,550,000,000.00

Net Margins-38.32%

Return on Equity8.63%

Return on Assets5.67%

Miscellaneous

Employees16,100

Outstanding Shares227,440,000

Dentsply Sirona (NASDAQ:XRAY) Frequently Asked Questions

What is Dentsply Sirona's stock symbol?

Dentsply Sirona trades on the NASDAQ under the ticker symbol "XRAY."

How often does Dentsply Sirona pay dividends? What is the dividend yield for Dentsply Sirona?

Dentsply Sirona announced a quarterly dividend on Wednesday, April 25th. Shareholders of record on Friday, June 29th will be paid a dividend of $0.0875 per share on Friday, July 13th. This represents a $0.35 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Thursday, June 28th. View Dentsply Sirona's Dividend History.

How were Dentsply Sirona's earnings last quarter?

Dentsply Sirona (NASDAQ:XRAY) released its quarterly earnings results on Sunday, May, 6th. The medical instruments supplier reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.03. The medical instruments supplier earned $956.10 million during the quarter, compared to analyst estimates of $942.20 million. Dentsply Sirona had a positive return on equity of 8.63% and a negative net margin of 38.32%. The business's revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. View Dentsply Sirona's Earnings History.

When is Dentsply Sirona's next earnings date?

Dentsply Sirona is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Dentsply Sirona.

What guidance has Dentsply Sirona issued on next quarter's earnings?

Dentsply Sirona issued an update on its FY18 earnings guidance on Monday, May, 7th. The company provided earnings per share guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.70.

What price target have analysts set for XRAY?

14 equities research analysts have issued twelve-month price objectives for Dentsply Sirona's shares. Their forecasts range from $52.00 to $75.00. On average, they expect Dentsply Sirona's share price to reach $62.0769 in the next twelve months. View Analyst Ratings for Dentsply Sirona.

What are Wall Street analysts saying about Dentsply Sirona stock?

Here are some recent quotes from research analysts about Dentsply Sirona stock:

1. According to Zacks Investment Research, "In the past year, DENTSPLY underperformed the industry. A lowered guidance is discouraging. The company's higher capital expenditure on product development and tough competition are expected to exert pressure on margins. Unfavorable foreign exchange rate and integration risks are major headwinds for the near term. However, DENTSPLY exited the first quarter on a solid note. Robust performance by the flagship dental implants, CAD/CAM systems, imaging systems, treatment centers and orthodontic product platforms hold considerable promise. Emerging markets like Asia-Pacific & the Middle East offer healthy growth opportunities, as they remain vastly untapped with low dental products penetration. The company’s agreements with MedTech bigwig Patterson Companies in Canada are likely to drive sales. DENTSPLY recently witnessed a rebound in sales in Asia, particularly Japan, and strong growth in Russia." (5/11/2018)
2. Jefferies Group LLC analysts commented, "Dynavax provided Phase 1b/2 updates on TLR9 agonist, SD-101 in combination with Keytruda, for head and neck squamous cell carcinoma (HNSCC) and metastatic melanoma at AACR." (4/16/2018)
3. Barrington Research analysts commented, "We are currently modeling adjusted EPS of $2.70 and this is unchanged versus our previous modeling. We suspect that the company will be able to overcome whatever modest dilution comes with this deal over the balance of 2018. That said, we have made some modest adjustments to our quarterly modeling and have attached a model, which is a bit more back-end loaded than previously. We are doing this in part to account for any additional costs associated with the efforts to put this transaction together as well as general conservatism associated with prior disclosures by management relative to the company’s ongoing efforts to work down its inventory levels with certain key distribution channels." (3/27/2018)

Are investors shorting Dentsply Sirona?

Dentsply Sirona saw a increase in short interest during the month of April. As of April 13th, there was short interest totalling 5,763,918 shares, an increase of 44.3% from the March 30th total of 3,995,125 shares. Based on an average daily volume of 2,405,346 shares, the days-to-cover ratio is currently 2.4 days. Currently, 2.5% of the company's shares are sold short.

Who are some of Dentsply Sirona's key competitors?

Some companies that are related to Dentsply Sirona include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), Biomerica (BMRA), Biolase (BIOL) and Remedent (REMI).

Who are Dentsply Sirona's key executives?

Dentsply Sirona's management team includes the folowing people:

Mr. Nicholas William Alexos, Exec. VP & CFO (Age 54)
Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 49)
Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 57)
Mr. Robert J. Size, Interim Pres & COO (Age 59)
Mr. Donald M. Casey Jr., CEO & Director (Age 58)

Has Dentsply Sirona been receiving favorable news coverage?

Media stories about XRAY stock have been trending positive recently, Accern reports. The research firm scores the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dentsply Sirona earned a media sentiment score of 0.37 on Accern's scale. They also gave news stories about the medical instruments supplier an impact score of 47.47 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are Dentsply Sirona's major shareholders?

Dentsply Sirona's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.28%), GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Veritas Asset Management LLP (3.70%), Principal Financial Group Inc. (3.02%), Massachusetts Financial Services Co. MA (2.34%) and Atlanta Capital Management Co. L L C (2.09%). Company insiders that own Dentsply Sirona stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Donald M Jr Casey, Eric Brandt, Francis J Lunger, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for Dentsply Sirona.

Which major investors are selling Dentsply Sirona stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Select Equity Group L.P., JPMorgan Chase & Co., Amundi Pioneer Asset Management Inc., Atlantic Trust Group LLC, Frontier Capital Management Co. LLC, Neuberger Berman Group LLC, Sei Investments Co. and Independent Franchise Partners LLP. Company insiders that have sold Dentsply Sirona company stock in the last year include Eric Brandt, Francis J Lunger and Michael J Coleman. View Insider Buying and Selling for Dentsply Sirona.

Which major investors are buying Dentsply Sirona stock?

XRAY stock was bought by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, SG Americas Securities LLC, Champlain Investment Partners LLC, Thompson Siegel & Walmsley LLC, Honeywell International Inc., Citigroup Inc., Prudential Financial Inc. and Tamarack Advisers LP. Company insiders that have bought Dentsply Sirona stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for Dentsply Sirona.

How do I buy shares of Dentsply Sirona?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dentsply Sirona's stock price today?

One share of XRAY stock can currently be purchased for approximately $47.25.

How big of a company is Dentsply Sirona?

Dentsply Sirona has a market capitalization of $10.74 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. Dentsply Sirona employs 16,100 workers across the globe.

How can I contact Dentsply Sirona?

Dentsply Sirona's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]

MarketBeat Community Rating for Dentsply Sirona (XRAY)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		257 (Vote Outperform)
Underperform Votes:		257 (Vote Underperform)
Total Votes:		514

MarketBeat's community ratings are surveys of what our community members think about Dentsply Sirona and other stocks. Vote "Outperform" if you believe XRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Dentsply Sirona (NASDAQ:XRAY) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

14 Wall Street analysts have issued ratings and price targets for Dentsply Sirona in the last 12 months. Their average twelve-month price target is $62.0769, suggesting that the stock has a possible upside of 31.38%. The high price target for XRAY is $75.00 and the low price target for XRAY is $52.00. There are currently 1 sell rating, 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.57	2.57	2.54	2.60
Ratings Breakdown:	1 Sell Rating(s) 4 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 4 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 4 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 2 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$62.0769	$67.00	$68.9167	$66.4444
Price Target Upside:	31.38% upside	33.49% upside	10.00% upside	4.46% upside

Dentsply Sirona (NASDAQ:XRAY) Consensus Price Target History

Price Target History for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/16/2018	Deutsche Bank	Lower Price Target	Buy	$55.00	Low
5/8/2018	Robert W. Baird	Lower Price Target	Outperform ➝ Outperform	$71.00	High
5/8/2018	Barrington Research	Lower Price Target	Outperform ➝ Outperform	$70.00 ➝ $54.00	High
5/8/2018	Barclays	Reiterated Rating	Hold	$55.00	High
5/8/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$67.00 ➝ $57.00	High
5/8/2018	HC Wainwright	Lower Price Target	Neutral ➝ Neutral	$63.00 ➝ $52.00	High
4/16/2018	Jefferies Group	Reiterated Rating	Buy		Low
4/5/2018	Cleveland Research	Reiterated Rating	Hold		Low
3/5/2018	JPMorgan Chase	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $70.00	Low
3/2/2018	Credit Suisse Group	Lower Price Target	Outperform ➝ Outperform	$73.00 ➝ $69.00	High
11/28/2017	Stephens	Initiated Coverage	Overweight	$75.00	Low
10/6/2017	Morgan Stanley	Reiterated Rating	Overweight	$67.00 ➝ $69.00	N/A
8/10/2017	UBS	Reiterated Rating	Neutral	$62.00 ➝ $59.00	Low
5/23/2017	Goldman Sachs	Downgrade	Neutral ➝ Sell	$60.00 ➝ $55.00	Medium
9/12/2016	Bank of America	Initiated Coverage	Buy	$70.00	N/A
6/27/2016	Piper Jaffray Companies	Reiterated Rating	Buy		N/A

(Data available from 5/23/2016 forward)

Dentsply Sirona (NASDAQ:XRAY) Earnings History and Estimates Chart

Earnings by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Earnings Estimates

2018 EPS Consensus Estimate: $2.57
2019 EPS Consensus Estimate: $2.84

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	$0.42	$0.43	$0.43
Q2 2018	4	$0.58	$0.62	$0.61
Q3 2018	4	$0.70	$0.72	$0.71
Q4 2018	4	$0.81	$0.83	$0.82
Q1 2019	3	$0.49	$0.63	$0.56
Q2 2019	3	$0.67	$0.76	$0.71
Q3 2019	3	$0.72	$0.78	$0.75
Q4 2019	3	$0.79	$0.87	$0.82

Dentsply Sirona (NASDAQ XRAY) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/7/2018		$0.60					N/A
5/6/2018	Q1 2018	$0.42	$0.45	$942.20 million	$956.10 million	View	N/A
3/1/2018	Q4 2017	$0.81	$0.82	$1.0607 billion	$1.0910 billion	View	Listen
11/3/2017	Q3 2017	$0.66	$0.70	$978.99 million	$1.0092 billion	View	N/A
8/9/2017	Q2 2017	$0.65	$0.65	$1.0032 billion	$992.70 million	View	Listen
5/9/2017	Q1 17	$0.50	$0.49	$916.55 million	$900.50 million	View	Listen
2/17/2017	Q4 2016	$0.65	$0.67	$1.0192 billion	$996.50 million	View	Listen
11/4/2016	Q316	$0.63	$0.66	$967.68 million	$954.20 million	View	Listen
8/5/2016	Q216	$0.70	$0.76	$1.03 billion	$1.02 billion	View	Listen
5/6/2016	Q1	$0.63	$0.69	$741.80 million	$772.60 million	View	N/A
2/12/2016	Q415	$0.65	$0.65	$687.35 million	$671.10 million	View	Listen
10/28/2015	Q3	$0.63	$0.66	$667.00 million	$648.90 million	View	Listen
7/30/2015	Q215	$0.68	$0.73	$715.49 million	$698.00 million	View	Listen
5/6/2015	Q115	$0.57	$0.59	$690.16 million	$656.30 million	View	Listen
2/18/2015	Q414	$0.61	$0.60	$751.04 million	$719.00 million	View	Listen
10/29/2014	Q314	$0.60	$0.62	$725.83 million	$708.00 million	View	Listen
7/31/2014	Q2	$0.68	$0.69	$782.86 million	$765.20 million	View	Listen
5/6/2014	Q1	$0.56	$0.59	$747.27 million	$730.10 million	View	Listen
2/18/2014	Q4	$0.61	$0.61	$767.89 million	$753.70 million	View	Listen
10/29/2013	Q313	$0.56	$0.57	$716.13 million	$704.00 million	View	Listen
8/1/2013	Q2 2013	$0.65	$0.66	$782.73 million	$761.00 million	View	Listen
5/9/2013	Q1 2013	$0.56	$0.52	$732.87 million	$732.10 million	View	Listen
2/20/2013	Q4 2012	$0.56	$0.56	$748.56 million	$753.30 million	View	Listen
10/25/2012		$0.50	$0.51			View	N/A
7/31/2012		$0.57	$0.62			View	N/A
5/1/2012		$0.52	$0.52			View	N/A
2/16/2012		$0.52	$0.51			View	N/A
10/27/2011		$0.43	$0.46			View	N/A
7/28/2011		$0.51	$0.55			View	N/A
4/28/2011		$0.48	$0.49			View	N/A
2/9/2011		$0.50	$0.51			View	N/A
10/28/2010	Q3 2010	$0.45	$0.45			View	N/A
7/29/2010	Q2 2010	$0.51	$0.50			View	N/A
4/29/2010	Q1 2010	$0.45	$0.44			View	N/A
2/10/2010	Q4 2009	$0.48	$0.48			View	N/A
10/28/2009	Q3 2009	$0.44	$0.44			View	N/A
7/29/2009	Q2 2009	$0.48	$0.49			View	N/A
4/30/2009	Q1 2009	$0.43	$0.43			View	N/A
2/4/2009	Q4 2008	$0.46	$0.45			View	N/A
10/28/2008	Q3 2008	$0.44	$0.46			View	N/A
7/29/2008	Q2 2008	$0.49	$0.53			View	N/A
4/30/2008	Q1 2008	$0.43	$0.45			View	N/A
2/5/2008	Q4 2007	$0.44	$0.46			View	N/A

(Earnings results data provided by Zacks Investment Research)

Dentsply Sirona (NASDAQ:XRAY) Dividend Information

Dentsply Sirona pays an annual dividend of $0.35 per share, with a dividend yield of 0.74%. XRAY's next quarterly dividend payment will be made on Friday, July 13. Dentsply Sirona pays out 13.16% of its earnings out as a dividend.

Next Dividend:	7/13/2018
Annual Dividend:	$0.35
Dividend Yield:	0.74%
Payout Ratio(s):	13.16% (Trailing 12 Months of Earnings) 13.57% (Based on This Year's Estimates) 12.20% (Based on Next Year's Estimates) 3.11% (Based on Cash Flow)

Dividend Payments by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/25/2018	quarterly	$0.0875	0.71%	6/28/2018	6/29/2018	7/13/2018
2/14/2018	quarterly	$0.0875	0.7%	3/28/2018	3/29/2018	4/13/2018
12/12/2017	quarterly	$0.0875	0.53%	12/28/2017	12/29/2017	1/12/2018
6/28/2017	quarterly	$0.0875	0.54%	9/28/2017	9/29/2017	10/13/2017
6/22/2017	quarterly	$0.0875	0.55%	6/28/2017	6/30/2017	7/14/2017
2/17/2017	quarterly	$0.0875	0.56%	3/29/2017	3/31/2017	4/13/2017
12/15/2016	quarterly	$0.0775	0.52%	12/28/2016	12/30/2016	1/13/2017
9/22/2016		$0.0775		9/28/2016	9/30/2016	10/14/2016
4/11/2016		$0.0780		6/22/2016	6/24/2016	7/8/2016
3/3/2016		$0.0780		3/22/2016	3/25/2016	4/8/2016
10/1/2015		$0.0720		12/22/2015	12/25/2015	1/8/2016
7/29/2015	quarterly	$0.0725		9/23/2015	9/25/2015	10/9/2015
5/20/2015	quarterly	$0.0725	0.55%	6/24/2015	6/26/2015	7/10/2015
2/24/2015	quarterly	$0.0725	0.54%	3/25/2015	3/27/2015	4/10/2015
9/25/2014	quarterly	$0.0663	0.58%	12/23/2014	12/26/2014	1/9/2015
8/1/2014	quarterly	$0.0663	0.57%	9/24/2014	9/26/2014	10/10/2014
5/22/2014	quarterly	$0.0663	0.57%	6/25/2014	6/27/2014	7/11/2014
2/18/2014	quarterly	$0.0663	0.59%	3/26/2014	3/28/2014	4/11/2014
9/27/2013	quarterly	$0.0625	0.58%	12/24/2013	12/27/2013	1/10/2014
8/1/2013	quarterly	$0.0625	0.58%	9/25/2013	9/27/2013	10/11/2013
5/23/2013	quarterly	$0.0625	0.6%	6/26/2013	6/28/2013	7/12/2013
2/27/2013	quarterly	$0.0625	0.61%	3/26/2013	3/29/2013	4/12/2013

(Data available from 1/1/2013 forward)

Dentsply Sirona (NASDAQ XRAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.93%
Institutional Ownership Percentage: 93.59%

Insider Trading History for Dentsply Sirona (NASDAQ:XRAY)

Institutional Ownership by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ XRAY) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2018	Michael J Coleman	Director	Sell	414	$46.66	$19,317.24	20,650
5/9/2018	Donald M Jr. Casey	CEO	Buy	22,500	$44.52	$1,001,700.00	92,408
5/9/2018	Nicholas W Alexos	CFO	Buy	50,000	$44.71	$2,235,500.00	25,411
1/8/2018	Eric Brandt	Director	Sell	6,409	$68.04	$436,068.36	12,073
11/13/2017	Francis J Lunger	Director	Sell	8,900	$65.90	$586,510.00
11/13/2017	Mark Thierer	Insider	Buy	77,000	$66.04	$5,085,080.00
11/13/2017	Nicholas W Alexos	CFO	Buy	50,000	$65.85	$3,292,500.00
4/24/2017	James G Mosch	CEO	Sell	50,600	$63.49	$3,212,594.00	105,083
4/7/2017	Christopher T Clark	CEO	Sell	89,700	$62.67	$5,621,499.00	112,067
3/9/2017	Ulrich Michel	Insider	Sell	24,000	$62.84	$1,508,160.00	94,067
3/2/2017	Eric Brandt	Director	Sell	2,941	$64.35	$189,253.35	4,722
3/1/2017	Bret W Wise	Insider	Sell	146,900	$64.17	$9,426,573.00	142,121
2/17/2017	Arthur D Kowaloff	Director	Sell	27,213	$62.00	$1,687,206.00	55,692
2/17/2017	Christopher T Clark	CEO	Sell	64,500	$60.70	$3,915,150.00	55,916
11/17/2016	James G Mosch	CEO	Sell	30,400	$60.93	$1,852,272.00	75,283
9/6/2016	Rainer Berthan	VP	Sell	5,000	$61.12	$305,600.00	34,370
8/25/2016	Maureen J Macinnis	SVP	Sell	45,100	$60.55	$2,730,805.00	36,730
8/23/2016	Maureen J Macinnis	SVP	Sell	17,650	$60.61	$1,069,766.50	19,630
6/2/2016	Rainer Berthan	VP	Sell	6,464	$62.56	$404,387.84	39,341
5/26/2016	Michael C Alfano	Director	Sell	3,000	$61.58	$184,740.00	8,758
5/16/2016	Harry M Jansen Kraemer Jr	Director	Sell	27,213	$62.17	$1,691,832.21	58,262
3/29/2016	Arthur D Kowaloff	Director	Sell	13,006	$62.00	$806,372.00	42,785
11/18/2015	Deborah Rasin	VP	Sell	4,500	$60.56	$272,520.00	4,429
11/4/2015	Michael C Alfano	Director	Sell	2,500	$62.15	$155,375.00	8,737
11/3/2015	Deborah Rasin	VP	Sell	14,000	$61.70	$863,800.00	8,929
3/30/2015	Christopher T Clark	Insider	Sell	85,566	$51.18	$4,379,267.88
2/20/2015	Deborah Rasin	VP	Sell	11,000	$52.47	$577,170.00
2/20/2015	Michael J Coleman	Director	Sell	18,000	$52.47	$944,460.00
1/9/2015	Robert J Size	VP	Sell	9,200	$52.97	$487,324.00
12/8/2014	Leslie A Jones	Director	Sell	18,000	$55.45	$998,100.00
12/4/2014	Albert Sterkenburg	VP	Sell	23,200	$55.62	$1,290,384.00
11/7/2014	Michael C Alfano	Director	Sell	20,000	$51.23	$1,024,600.00
11/5/2014	James G Mosch	VP	Sell	55,042	$51.25	$2,820,902.50
11/4/2014	Francis J Lunger	Director	Sell	9,160	$50.90	$466,244.00
10/31/2014	Albert Sterkenburg	VP	Sell	2,000	$50.51	$101,020.00
10/31/2014	John C Miles II	Director	Sell	20,000	$50.65	$1,013,000.00
8/25/2014	Leslie A Jones	Director	Sell	2,000	$48.30	$96,600.00
7/3/2014	Christopher T Clark	Insider	Sell	27,521	$47.74	$1,313,852.54
5/30/2014	Michael C Alfano	Director	Sell	2,764	$47.25	$130,599.00
5/19/2014	Leslie Jones	Director	Sell	2,000	$46.49	$92,980.00	95,892
5/12/2014	Robert Size	VP	Sell	5,049	$46.29	$233,718.21	11,588
12/11/2013	Bret Wise	Chairman	Sell	90,000	$48.50	$4,365,000.00	21,724
12/9/2013	Francis Lunger	Director	Sell	18,000	$47.66	$857,880.00	4,322
12/6/2013	Bret Wise	Chairman	Sell	24,323	$47.66	$1,159,234.18	30,294
12/2/2013	Bret Wise	Chairman	Sell	66,761	$47.53	$3,173,150.33	30,294
12/2/2013	William Hecht	Director	Sell	18,000	$47.49	$854,820.00	18,000
11/8/2013	Leslie Jones	Director	Sell	2,000	$47.68	$95,360.00	97,892
10/21/2013	Robert J Size	VP	Sell	14,262	$46.00	$656,052.00
9/11/2013	Robert Size	VP	Sell	8,200	$45.00	$369,000.00	11,501
9/10/2013	James G Mosch	VP	Sell	41,836	$43.95	$1,838,692.20
7/31/2013	Christopher T Clark	Insider	Sell	20,918	$43.00	$899,474.00
7/31/2013	Eric Brandt	Director	Sell	18,000	$43.00	$774,000.00
7/9/2013	Christopher T Clark	Insider	Sell	20,918	$42.00	$878,556.00
6/3/2013	Leslie A Jones	Director	Sell	2,840	$41.76	$118,598.40
3/12/2013	Paula H Cholmondeley	Director	Sell	9,000	$42.70	$384,300.00
12/21/2012	Bret W Wise	Chairman	Sell	4,349	$40.50	$176,134.50

(Data available from 1/1/2013 forward)

Dentsply Sirona (NASDAQ XRAY) News Headlines

Source:

Date	Headline
	Here's Why You Should Sell DENTSPLY SIRONA (XRAY) Stock Now www.zacks.com - May 18 at 8:03 AM
	Dentsply Sirona (XRAY) Upgraded at ValuEngine www.americanbankingnews.com - May 16 at 4:51 PM
	Dentsply Sirona (XRAY) Given New $55.00 Price Target at Deutsche Bank www.americanbankingnews.com - May 16 at 1:49 PM
	Dentsply Sirona (XRAY) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - May 15 at 3:44 AM
	Analysts Expect Dentsply Sirona (XRAY) Will Post Quarterly Sales of $1.03 Billion www.americanbankingnews.com - May 15 at 2:48 AM
	Brokerages Expect Dentsply Sirona (XRAY) Will Announce Earnings of $0.60 Per Share www.americanbankingnews.com - May 13 at 1:24 PM
	Zacks Investment Research Downgrades Dentsply Sirona (XRAY) to Sell www.americanbankingnews.com - May 11 at 6:31 PM
	Insider Selling: Dentsply Sirona (XRAY) Director Sells 414 Shares of Stock www.americanbankingnews.com - May 11 at 4:46 PM
	Dentsply Sirona (XRAY) to Post Q2 2018 Earnings of $0.58 Per Share, Barrington Research Forecasts www.americanbankingnews.com - May 11 at 8:15 AM
	Barrington Research Analysts Decrease Earnings Estimates for Dentsply Sirona (XRAY) www.americanbankingnews.com - May 10 at 7:58 AM
	Q3 2018 Earnings Forecast for Dentsply Sirona (XRAY) Issued By William Blair www.americanbankingnews.com - May 10 at 7:16 AM
	Research Analysts Offer Predictions for Dentsply Sirona's Q2 2018 Earnings (XRAY) www.americanbankingnews.com - May 10 at 6:14 AM
	Insider Buying: Dentsply Sirona (XRAY) CEO Buys 22,500 Shares of Stock www.americanbankingnews.com - May 9 at 7:37 PM
	Dentsply Sirona (XRAY) CFO Nicholas W. Alexos Purchases 50,000 Shares www.americanbankingnews.com - May 9 at 7:17 PM
	Edited Transcript of XRAY earnings conference call or presentation 7-May-18 12:30pm GMT finance.yahoo.com - May 9 at 5:54 PM
	Q3 2018 Earnings Estimate for Dentsply Sirona Issued By Jefferies Group (XRAY) www.americanbankingnews.com - May 9 at 8:39 AM
	Q2 2018 EPS Estimates for Dentsply Sirona (XRAY) Decreased by Analyst www.americanbankingnews.com - May 9 at 8:23 AM
	Q2 2018 EPS Estimates for Dentsply Sirona Decreased by William Blair (XRAY) www.americanbankingnews.com - May 9 at 8:23 AM
	ValuEngine Lowers Dentsply Sirona (XRAY) to Strong Sell www.americanbankingnews.com - May 8 at 11:26 PM
	DENTSPLY SIRONA is Now Oversold (XRAY) www.nasdaq.com - May 8 at 5:57 PM
	Dentsply Sirona (XRAY) Stock Rating Reaffirmed by Barclays www.americanbankingnews.com - May 8 at 3:45 PM
	Dentsply Sirona (XRAY) Stock Rating Reaffirmed by Stifel Nicolaus www.americanbankingnews.com - May 8 at 3:32 PM
	Robert W. Baird Lowers Dentsply Sirona (XRAY) Price Target to $56.00 www.americanbankingnews.com - May 8 at 3:29 PM
	Dentsply Sirona (XRAY) Price Target Cut to $52.00 by Analysts at HC Wainwright www.americanbankingnews.com - May 8 at 1:23 PM
	Dentsply Sirona (XRAY) Posts Quarterly Earnings Results www.americanbankingnews.com - May 8 at 11:32 AM
	Dentsply Sirona (XRAY) Price Target Cut to $54.00 by Analysts at Barrington Research www.americanbankingnews.com - May 8 at 10:22 AM
	Dentsply Sirona Q1 Results Top Estimates; But Cuts 2018 Outlook www.nasdaq.com - May 7 at 5:50 PM
	Dentsply Sirona (XRAY) Releases FY18 Earnings Guidance www.americanbankingnews.com - May 7 at 9:16 AM
	Dentsply: 1Q Earnings Snapshot finance.yahoo.com - May 7 at 8:06 AM
	Will Dentsply Sirona Recover from Its Recent Stock Price Lows? finance.yahoo.com - May 7 at 8:06 AM
	Should You Buy DENTSPLY SIRONA Inc (NASDAQ:XRAY)? finance.yahoo.com - May 6 at 7:58 PM
	Head to Head Analysis: Sartorius (SARTF) & Dentsply Sirona (XRAY) www.americanbankingnews.com - May 6 at 5:53 AM
	What's in Store for DENTSPLY (XRAY) This Earnings Season? www.msn.com - May 3 at 8:02 AM
	What's in Store for DENTSPLY (XRAY) This Earnings Season? finance.yahoo.com - May 2 at 5:49 PM
	Head to Head Comparison: Sartorius (SARTF) vs. Dentsply Sirona (XRAY) www.americanbankingnews.com - May 2 at 5:44 PM
	Dentsply Sirona (XRAY) Downgraded by ValuEngine to Sell www.americanbankingnews.com - May 2 at 1:13 PM
	Wall Street Analysts Raise Target Prices on ALGN after 1Q18 Earnings finance.yahoo.com - April 30 at 8:02 AM
	Dentsply Sirona (XRAY) Scheduled to Post Quarterly Earnings on Sunday www.americanbankingnews.com - April 29 at 5:32 AM
	Financial Contrast: Dentsply Sirona (XRAY) vs. Biolase (BIOL) www.americanbankingnews.com - April 28 at 3:32 PM
	Zacks: Analysts Expect Dentsply Sirona (XRAY) Will Announce Quarterly Sales of $944.67 Million www.americanbankingnews.com - April 28 at 4:58 AM
	Head to Head Contrast: Dentsply Sirona (XRAY) and Biolase (BIOL) www.americanbankingnews.com - April 26 at 9:40 PM
	Global Dental Market Size, Trends & Forecasts 2018-2022 with Dentsply Sirona, Danaher, 3M Company & Planmeca Group Playing Key Roles www.prnewswire.com - April 26 at 6:10 PM
	Al Gore’s Firm Is Buying These Two Stocks www.barrons.com - April 26 at 5:27 PM
	Al Gore's Firm Is Buying These Two Stocks finance.yahoo.com - April 26 at 5:27 PM
	Analysts Expect Dentsply Sirona (XRAY) Will Announce Earnings of $0.43 Per Share www.americanbankingnews.com - April 26 at 3:16 AM
	Dentsply Sirona (XRAY) Short Interest Update www.americanbankingnews.com - April 26 at 2:22 AM
	Dentsply Sirona (XRAY) Declares Quarterly Dividend of $0.09 www.americanbankingnews.com - April 25 at 6:52 PM
	Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7th finance.yahoo.com - April 25 at 5:41 PM
	Dentsply Sirona Target of Unusually Large Options Trading (XRAY) www.americanbankingnews.com - April 24 at 6:43 AM
	Dentsply Sirona (XRAY) versus Straumann (SAUHF) Financial Review www.americanbankingnews.com - April 23 at 9:14 AM

Dentsply Sirona (NASDAQ:XRAY) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Dentsply Sirona (NASDAQ:XRAY) Income Statement, Balance Sheet and Cash Flow Statement

Dentsply Sirona (NASDAQ XRAY) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff